Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
CONy 2023
ACTRIMS 2023
ISC 2023
EHC 2022
AES 2022
WSC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Huntington’s Disease
4:14
Update on huntingtin-lowering strategies under investigation for Huntington’s disease
Ann Morgan
et al.
• 16 Sep 2022
0:50
The impact of wild-type HTT suppression on brain function
Ann Morgan
et al.
• 16 Sep 2022
2:13
Improving CNS delivery and distribution of Huntington’s disease therapies
Ann Morgan
et al.
• 16 Sep 2022
2:13
ASOs as therapeutic strategies in movement disorders
Tiago Outeiro
• 17 Sep 2022
5:08
PTC518: oral splicing modifier under investigation for the treatment of Huntington’s disease
Amy-Lee Bredlau
et al.
• 16 Sep 2022
3:35
Phase II PIOVT-HD trial of PTC518 in early Huntington’s disease
Amy-Lee Bredlau
et al.
• 16 Sep 2022
1:09
Monitoring children at risk for juvenile Huntington’s disease
Ferdinando Squitieri
• 3 Oct 2022
1:12
Improving data collection in Juvenile Huntington’s disease
Ferdinando Squitieri
• 3 Oct 2022
3:03
Pridopidine application beyond Huntington’s disease
Michael Hayden
• 27 Sep 2022
5:38
PROOF-HD: Phase III trial of oral S1R agonist pridopidine for the treatment of Huntington’s disease
Michael Hayden
• 27 Sep 2022
4:57
Huntingtin function in health and disease: axonal transport
Frederic Saudou
• 20 Sep 2022
3:35
Symptoms of juvenile onset Huntington’s disease
Ferdinando Squitieri
• 3 Oct 2022
2:06
Advancing mHTT as a biomarker in Huntington’s disease
Lauren Byrne
• 23 Sep 2022
2:05
Tackling cognitive impairment in Huntington’s disease: a significant unmet need
Aaron Koenig
• 22 Sep 2022
1:56
Strategies to improve ASOs in Huntington’s disease
Patrick Weydt
• 23 Sep 2022
2:21
Huntingtin lowering: what level of wildtype protein knockdown is safe?
Michael Hayden
• 27 Sep 2022
1
2
3
4
5
Next